Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 11, 2022
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
Geulah Livshits Maintained (TNYA) at Strong Buy with Decreased Target to $30 on, Aug 11th, 2022
Geulah Livshits of Chardan Capital, Maintained "Tenaya Therapeutics, Inc." (TNYA) at Strong Buy with Decreased Target from $31 to $30 on, Aug 11th, 2022.
Geulah has made no other calls on TNYA in the last 4 months.
There are 2 other peers that have a rating on TNYA. Out of the 2 peers that are also analyzing TNYA, 0 agree with Geulah's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Geulah
- Joseph Pantginis of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $25 on, Wednesday, June 15th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $15 on, Tuesday, May 17th, 2022
